Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study

Among non-dialysis-dependent chronic kidney disease (ND-CKD) patients, a low hematopoietic response to erythropoiesis-stimulating agents (ESAs) is a predictor for poor renal and cardiovascular outcome. To assess the method for evaluating hyporesponsiveness to ESA in patients with ND-CKD, a multicent...

Descripción completa

Detalles Bibliográficos
Autores principales: Narita, Ichiei, Hayashi, Terumasa, Maruyama, Shoichi, Masaki, Takao, Nangaku, Masaomi, Nishino, Tomoya, Sato, Hiroshi, Sofue, Tadashi, Wada, Takashi, Imai, Enyu, Iwasaki, Manabu, Mizuno, Kyoichi, Hase, Hiroki, Kamouchi, Masahiro, Yamamoto, Hiroyasu, Kagimura, Tatsuo, Tanabe, Kenichiro, Kato, Hideki, Wada, Takehiko, Usui, Tomoko, Akizawa, Tadao, Hirakata, Hideki, Tsubakihara, Yoshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707758/
https://www.ncbi.nlm.nih.gov/pubmed/36445882
http://dx.doi.org/10.1371/journal.pone.0277921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707758/
https://www.ncbi.nlm.nih.gov/pubmed/36445882
http://dx.doi.org/10.1371/journal.pone.0277921

Ejemplares similares